Rezolute (RZLT) Times Interest Earned (2012 - 2026)
Rezolute (RZLT) reported Times Interest Earned of -$5.11 for Q1 2026, down 7.14% on a YoY basis from -$5.5 in Q1 2025, and up 47.28% sequentially from -$9.69 in Q4 2025.
Rezolute (RZLT) Times Interest Earned (2012 - 2026) Analysis & Trends
Rezolute (RZLT) has 15 years of Times Interest Earned data on file, last reported at -$5.11 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 7.14% year-over-year to -$5.11; the trailing twelve-month figure through Mar 2026 stood at -$25.66 (down 39.71% YoY), and the FY2025 full-year result was -$0.89, up 81.58% from the prior year.
- Times Interest Earned rose to -$5.11 in Q1 2026, from -$9.69 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.27 in Q3 2025 to a low of -$136.77 in Q2 2025.
- A 5-year average of -$35.16 and a median of -$15.36 in 2022 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned jumped 97.97% in 2024 and slumped 989.09% in 2025, its largest moves.
- Tracing RZLT's Times Interest Earned over 5 years: stood at -$24.07 in 2022, then slumped by 82.46% to -$43.91 in 2023, then jumped by 97.97% to -$0.89 in 2024, then tumbled by 989.09% to -$9.69 in 2025, then jumped by 47.28% to -$5.11 in 2026.
- Business Quant data shows RZLT's Times Interest Earned at -$5.11 in Q1 2026, -$9.69 in Q4 2025, and -$0.27 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Rezolute | 518.12 Mn | 518.12 Mn | - | -5.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.11 |
| Dec 31, 2025 | -9.69 |
| Sep 30, 2025 | -0.27 |
| Jun 30, 2025 | -136.77 |
| Mar 31, 2025 | -4.77 |
| Dec 31, 2024 | -0.89 |
| Sep 30, 2024 | -0.88 |
| Jun 30, 2024 | -125.55 |
| Mar 31, 2024 | -4.50 |
| Dec 31, 2023 | -43.91 |
| Sep 30, 2023 | -23.89 |
| Jun 30, 2023 | -111.23 |
| Mar 31, 2023 | -5.85 |
| Dec 31, 2022 | -24.07 |
| Sep 30, 2022 | -61.19 |
| Jun 30, 2022 | -23.74 |
| Mar 31, 2022 | -15.36 |
| Dec 31, 2021 | -17.36 |
| Sep 30, 2021 | -10.91 |
| Jun 30, 2021 | -276.50 |